Further analysis of other significant targets (e.g., ASV, AURKA, MDM2, PLZF, FOS, etc.)will be equally important to search for the most prominent markers that can influence the heterogeneity of HCC cells. The gene discussed is FOS; the disease is hepatocellular carcinoma.